{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:15:58Z","timestamp":1716164158366},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,19]]},"DOI":"10.7759\/cureus.60616","type":"journal-article","created":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T20:03:43Z","timestamp":1716149023000},"source":"Crossref","is-referenced-by-count":0,"title":["Bleeding Outcomes of Direct Oral Anticoagulants and Vitamin K Antagonists for Acute Venous Thromboembolism: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Zeeshan","family":"Javaid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakeel Ahmad","family":"Awan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Babar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zia","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.3690","article-title":"Risk and risk factors associated with recurrent venous thromboembolism following surgery in patients with history of venous thromboembolism","volume":"2","author":"Nemeth B","year":"2019","unstructured":"Nemeth B, Lijfering WM, Nelissen RG, Schipper IB, Rosendaal FR, le Cessie S, Cannegieter SC. Risk and risk factors associated with recurrent venous thromboembolism following surgery in patients with history of venous thromboembolism. JAMA Netw Open. 2019, 2:e193690. 10.1001\/jamanetworkopen.2019.3690","journal-title":"JAMA Netw Open"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000818","article-title":"Venous thromboembolism research priorities: a scientific statement from the American Heart Association and the International Society on Thrombosis and Haemostasis","volume":"142","author":"Cushman M","year":"2020","unstructured":"Cushman M, Barnes GD, Creager MA, et al.. Venous thromboembolism research priorities: a scientific statement from the American Heart Association and the International Society on Thrombosis and Haemostasis. Circulation. 2020, 142:e85-94. 10.1161\/CIR.0000000000000818","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.10.040","article-title":"Trends in hospitalization and in-hospital mortality from VTE, 2007 to 2016, in China","volume":"155","author":"Zhang Z","year":"2019","unstructured":"Zhang Z, Lei J, Shao X, et al.. Trends in hospitalization and in-hospital mortality from VTE, 2007 to 2016, in China. Chest. 2019, 155:342-53. 10.1016\/j.chest.2018.10.040","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.07.070","article-title":"Antithrombotic management of venous thromboembolism: JACC focus seminar","volume":"76","author":"Renner E","year":"2020","unstructured":"Renner E, Barnes GD. Antithrombotic management of venous thromboembolism: JACC focus seminar. J Am Coll Cardiol. 2020, 76:2142-54. 10.1016\/j.jacc.2020.07.070","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30354-6","article-title":"Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database","volume":"8","author":"Barco S","year":"2020","unstructured":"Barco S, Mahmoudpour SH, Valerio L, et al.. Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database. Lancet Respir Med. 2020, 8:277-87. 10.1016\/S2213-2600(19)30354-6","journal-title":"Lancet Respir Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob GE","year":"2014","unstructured":"Raskob GE, Angchaisuksiri P, Blanco AN, et al.. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014, 34:2363-71. 10.1161\/ATVBAHA.114.304488","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor\u2019s choice - European Society for Vascular Surgery (ESVs) 2021 clinical practice guidelines on the management of venous thrombosis","volume":"61","author":"Kakkos SK","year":"2021","unstructured":"Kakkos SK, Gohel M, Baekgaard N, et al.. Editor\u2019s choice - European Society for Vascular Surgery (ESVs) 2021 clinical practice guidelines on the management of venous thrombosis. Eur J Vasc Endovasc Surg. 2021, 61:9-82. 10.1016\/j.ejvs.2020.09.023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es N","year":"2014","unstructured":"van Es N, Coppens M, Schulman S, Middeldorp S, B\u00fcller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 2014, 124:1968-75. 10.1182\/blood-2014-04-571232","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartjsupp\/suac121.572","article-title":"Safety of novel oral anticoagulants compared to vitamin K antagonists in the treatment of venous thromboembolism: a systematic review and meta-analysis","volume":"24","author":"Ridolfi L","year":"2022","unstructured":"Ridolfi L, Masini G, Castiglione V, et al.. Safety of novel oral anticoagulants compared to vitamin K antagonists in the treatment of venous thromboembolism: a systematic review and meta-analysis. Eur Heart J Suppl. 2022, 24:121-572. 10.1093\/eurheartjsupp\/suac121.572","journal-title":"Eur Heart J Suppl"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000000903","article-title":"Direct oral anticoagulants vs. vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis","volume":"85","author":"Shah BB","year":"2023","unstructured":"Shah BB, Shankar A, Kumar V, et al.. Direct oral anticoagulants vs. vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis. Ann Med Surg (Lond). 2023, 85:3574-82. 10.1097\/MS9.0000000000000903","journal-title":"Ann Med Surg (Lond)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.122.039579","article-title":"Direct oral anticoagulants versus vitamin K antagonists in cerebral venous thrombosis: a systematic review and meta-analysis","volume":"53","author":"Yaghi S","year":"2022","unstructured":"Yaghi S, Saldanha IJ, Misquith C, et al.. Direct oral anticoagulants versus vitamin K antagonists in cerebral venous thrombosis: a systematic review and meta-analysis. Stroke. 2022, 53:3014-24. 10.1161\/STROKEAHA.122.039579","journal-title":"Stroke"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12718","article-title":"Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus","volume":"7","author":"Iqbal H","year":"2020","unstructured":"Iqbal H, Straw S, Craven TP, Stirling K, Wheatcroft SB, Witte KK. Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus. ESC Heart Fail. 2020, 7:2032-41. 10.1002\/ehf2.12718","journal-title":"ESC Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman S","year":"2005","unstructured":"Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005, 3:692-4. 10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2023.03.011","article-title":"Direct-acting oral anticoagulants in antiphospholipid syndrome: a systematic review","volume":"161","author":"Gir\u00f3n-Ortega JA","year":"2023","unstructured":"Gir\u00f3n-Ortega JA, Gir\u00f3n-Gonz\u00e1lez JA. Direct-acting oral anticoagulants in antiphospholipid syndrome: a systematic review. Med Clin (Barc). 2023, 161:65-77. 10.1016\/j.medcli.2023.03.011","journal-title":"Med Clin (Barc)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7326\/J23-0016","article-title":"In thrombotic antiphospholipid syndrome, DOACs vs. VKAs increase arterial thrombotic events but not major bleeding","volume":"176","author":"Koutroumpakis E","year":"2023","unstructured":"Koutroumpakis E, Deswal A. In thrombotic antiphospholipid syndrome, DOACs vs. VKAs increase arterial thrombotic events but not major bleeding. Ann Intern Med. 2023, 176:JC43. 10.7326\/J23-0016","journal-title":"Ann Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216382","article-title":"Vitamin-K antagonists vs. direct oral anticoagulants on severity of upper gastrointestinal bleeding: a retrospective analysis of Italian and UK data","volume":"11","author":"Brigida M","year":"2022","unstructured":"Brigida M, Di Caro S, Petruzziello C, Saviano A, Riccioni ME, Franceschi F, Ojetti V. Vitamin-K antagonists vs. direct oral anticoagulants on severity of upper gastrointestinal bleeding: a retrospective analysis of Italian and UK data. J Clin Med. 2022, 11:10.3390\/jcm11216382","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2023.03.008","article-title":"Mortality on DOACs versus on vitamin K antagonists in atrial fibrillation: analysis of the Hungarian Health Insurance Fund database","volume":"45","author":"Papp T","year":"2023","unstructured":"Papp T, Kiss Z, Rokszin G, et al.. Mortality on DOACs versus on vitamin K antagonists in atrial fibrillation: analysis of the Hungarian Health Insurance Fund database. Clin Ther. 2023, 45:333-46. 10.1016\/j.clinthera.2023.03.008","journal-title":"Clin Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252549","article-title":"Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus","volume":"16","author":"Kido K","year":"2021","unstructured":"Kido K, Ghaffar YA, Lee JC, Bianco C, Shimizu M, Shiga T, Hashiguchi M. Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus. PLoS One. 2021, 16:e0252549. 10.1371\/journal.pone.0252549","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2020.0312","article-title":"Severe hemorrhage associated with oral anticoagulants\u2014a prospective observational study of the clinical course during treatment with vitamin K antagonists or direct oral anticoagulants","volume":"117","author":"Lindhoff-Last E","year":"2020","unstructured":"Lindhoff-Last E, Herrmann E, Lindau S, et al.. Severe hemorrhage associated with oral anticoagulants\u2014a prospective observational study of the clinical course during treatment with vitamin K antagonists or direct oral anticoagulants. Dtsch Arztebl Int. 2020, 117:312-9. 10.3238\/arztebl.2020.0312","journal-title":"Dtsch Arztebl Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.02.009","article-title":"Direct oral anticoagulant- or warfarin-related major bleeding: characteristics, reversal strategies, and outcomes from a multicenter observational study","volume":"152","author":"Xu Y","year":"2017","unstructured":"Xu Y, Schulman S, Dowlatshahi D, et al.. Direct oral anticoagulant- or warfarin-related major bleeding: characteristics, reversal strategies, and outcomes from a multicenter observational study. Chest. 2017, 152:81-91. 10.1016\/j.chest.2017.02.009","journal-title":"Chest"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.11.117","article-title":"Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life","volume":"227","author":"Becattini C","year":"2017","unstructured":"Becattini C, Franco L, Beyer-Westendorf J, et al.. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life. Int J Cardiol. 2017, 227:261-6. 10.1016\/j.ijcard.2016.11.117","journal-title":"Int J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/253288-bleeding-outcomes-of-direct-oral-anticoagulants-and-vitamin-k-antagonists-for-acute-venous-thromboembolism-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T20:03:47Z","timestamp":1716149027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/253288-bleeding-outcomes-of-direct-oral-anticoagulants-and-vitamin-k-antagonists-for-acute-venous-thromboembolism-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,19]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.60616","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,19]]}}}